Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessPKR/eIFalpha signaling

ARIH1 HERC5

8.89e-062622GO:0039585
GeneOntologyCellularComponentsynaptonemal complex

POLB TEX11 HSPA2

2.97e-0446593GO:0000795
GeneOntologyCellularComponentsynaptonemal structure

POLB TEX11 HSPA2

2.97e-0446593GO:0099086
DomainEGF_LAM_2

LAMB4 STAB2 LAMA2

1.26e-0430613PS50027
DomainEGF_LAM_1

LAMB4 STAB2 LAMA2

1.26e-0430613PS01248
DomainEGF_Lam

LAMB4 STAB2 LAMA2

2.01e-0435613SM00180
DomainLaminin_EGF

LAMB4 STAB2 LAMA2

2.58e-0438613IPR002049
DomainLaminin_N

LAMB4 LAMA2

1.22e-0316612IPR008211
DomainLAMININ_NTER

LAMB4 LAMA2

1.22e-0316612PS51117
DomainLaminin_N

LAMB4 LAMA2

1.22e-0316612PF00055
DomainLamNT

LAMB4 LAMA2

1.22e-0316612SM00136
DomainIQ

MYH2 LRRIQ1 MYO1B

1.62e-0371613PF00612
DomainIQ

MYH2 LRRIQ1 MYO1B

2.36e-0381613SM00015
DomainIQ_motif_EF-hand-BS

MYH2 LRRIQ1 MYO1B

3.18e-0390613IPR000048
DomainIQ

MYH2 LRRIQ1 MYO1B

3.49e-0393613PS50096
Domain-

STAB2 SFTPA2 SFTPA1

3.93e-03976133.10.100.10
DomainC-type_lectin-like/link

STAB2 SFTPA2 SFTPA1

4.16e-0399613IPR016186
DomainCTDL_fold

STAB2 SFTPA2 SFTPA1

5.17e-03107613IPR016187
DomainLaminin_EGF

LAMB4 LAMA2

5.83e-0335612PF00053
Domain-

PDS5B ARID1B UNC45B PKP2

5.97e-032226141.25.10.10
DomainBROMODOMAIN_1

BAZ1A BRWD3

6.49e-0337612PS00633
DomainMyosin_head_motor_dom

MYH2 MYO1B

6.84e-0338612IPR001609
DomainBromodomain

BAZ1A BRWD3

6.84e-0338612PF00439
Pubmed

Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.

TPP2 BAZ1A FANCI SYNE2 MYO1B PEAK1 NEB

1.74e-0632262726514267
Pubmed

Major Effect of Oxidative Stress on the Male, but Not Female, SP-A1 Type II Cell miRNome.

SFTPA2 SFTPA1

3.13e-06262231354704
Pubmed

Signaling Pathways That Mediate Alveolar Macrophage Activation by Surfactant Protein A and IL-4.

SFTPA2 SFTPA1

3.13e-06262235444643
Pubmed

Genetic Variation in Surfactant Protein-A2 Delays Resolution of Eosinophilia in Asthma.

SFTPA2 SFTPA1

3.13e-06262231350355
Pubmed

Genetic complexity of the human surfactant-associated proteins SP-A1 and SP-A2.

SFTPA2 SFTPA1

3.13e-06262223069847
Pubmed

Ablation of SP-A has a negative impact on the susceptibility of mice to Klebsiella pneumoniae infection after ozone exposure: sex differences.

SFTPA2 SFTPA1

3.13e-06262219055785
Pubmed

Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo.

SFTPA2 SFTPA1

3.13e-06262210749762
Pubmed

Human Surfactant Protein SP-A1 and SP-A2 Variants Differentially Affect the Alveolar Microenvironment, Surfactant Structure, Regulation and Function of the Alveolar Macrophage, and Animal and Human Survival Under Various Conditions.

SFTPA2 SFTPA1

3.13e-06262234484180
Pubmed

The flagellum of Pseudomonas aeruginosa is required for resistance to clearance by surfactant protein A.

SFTPA2 SFTPA1

3.13e-06262217593964
Pubmed

Surfactant protein A limits Pneumocystis murina infection in immunosuppressed C3H/HeN mice and modulates host response during infection.

SFTPA2 SFTPA1

3.13e-06262215857803
Pubmed

Surfactant protein-A reduces translocation of mediators from the lung into the circulation.

SFTPA2 SFTPA1

3.13e-06262220715984
Pubmed

Studies of the structure of lung surfactant protein SP-A.

SFTPA2 SFTPA1

3.13e-0626222610270
Pubmed

Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice.

SFTPA2 SFTPA1

3.13e-0626229922219
Pubmed

Maternal surfactant protein A influences the immunoprotective properties of milk in a murine model.

SFTPA2 SFTPA1

3.13e-06262224858142
Pubmed

Effects of surfactant protein-A on the interaction of Pneumocystis murina with its host at different stages of the infection in mice.

SFTPA2 SFTPA1

3.13e-06262219335775
Pubmed

Surfactant protein-A--deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus.

SFTPA2 SFTPA1

3.13e-06262211867335
Pubmed

Altered surfactant protein A gene expression and protein metabolism associated with repeat exposure to inhaled endotoxin.

SFTPA2 SFTPA1

3.13e-06262212922979
Pubmed

Pneumocystis murina colonization in immunocompetent surfactant protein A deficient mice following environmental exposure.

SFTPA2 SFTPA1

3.13e-06262219228388
Pubmed

SP-A preserves airway homeostasis during Mycoplasma pneumoniae infection in mice.

SFTPA2 SFTPA1

3.13e-06262219494306
Pubmed

An 11-nt sequence polymorphism at the 3'UTR of human SFTPA1 and SFTPA2 gene variants differentially affect gene expression levels and miRNA regulation in cell culture.

SFTPA2 SFTPA1

3.13e-06262224793167
Pubmed

Sex differences in the acute in vivo effects of different human SP-A variants on the mouse alveolar macrophage proteome.

SFTPA2 SFTPA1

3.13e-06262224954098
Pubmed

Characterization of a second human pulmonary surfactant-associated protein SP-A gene.

SFTPA2 SFTPA1

3.13e-0626221372511
Pubmed

Lung effector memory and activated CD4+ T cells display enhanced proliferation in surfactant protein A-deficient mice during allergen-mediated inflammation.

SFTPA2 SFTPA1

3.13e-06262221257967
Pubmed

The Pseudomonas aeruginosa flagellum confers resistance to pulmonary surfactant protein-A by impacting the production of exoproteases through quorum-sensing.

SFTPA2 SFTPA1

3.13e-06262221205009
Pubmed

Surfactant protein A modulates neuroinflammation in adult mice upon pulmonary infection.

SFTPA2 SFTPA1

3.13e-06262238964703
Pubmed

Cryptococcus neoformans is resistant to surfactant protein A mediated host defense mechanisms.

SFTPA2 SFTPA1

3.13e-06262218159253
Pubmed

Differential Regulation of Human Surfactant Protein A Genes, SFTPA1 and SFTPA2, and Their Corresponding Variants.

SFTPA2 SFTPA1

3.13e-06262234917085
Pubmed

Surfactant protein A integrates activation signal strength to differentially modulate T cell proliferation.

SFTPA2 SFTPA1

3.13e-06262222219327
Pubmed

Surfactant protein A is a principal and oxidation-sensitive microbial permeabilizing factor in the alveolar lining fluid.

SFTPA2 SFTPA1

3.13e-06262215890661
Pubmed

Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species.

SFTPA2 SFTPA1

3.13e-06262215385504
Pubmed

Differences in the alveolar macrophage toponome in humanized SP-A1 and SP-A2 transgenic mice.

SFTPA2 SFTPA1

3.13e-06262233141765
Pubmed

A TLR4-interacting SPA4 peptide inhibits LPS-induced lung inflammation.

SFTPA2 SFTPA1

3.13e-06262223475791
Pubmed

Regulatory roles of SP-A and exosomes in pneumonia-induced acute lung and kidney injuries.

SFTPA2 SFTPA1

3.13e-06262237256132
Pubmed

Surfactant protein A associated with respiratory distress syndrome in Korean preterm infants: evidence of ethnic difference.

SFTPA2 SFTPA1

3.13e-06262223038062
Pubmed

Surfactant protein A binds flagellin enhancing phagocytosis and IL-1β production.

SFTPA2 SFTPA1

3.13e-06262224312669
Pubmed

Surfactant protein a attenuates generalized and localized neuroinflammation in neonatal mice.

SFTPA2 SFTPA1

3.13e-06262236871846
Pubmed

Correlation analysis between single nucleotide polymorphisms of pulmonary surfactant protein A gene and pulmonary tuberculosis in the Han population in China.

SFTPA2 SFTPA1

3.13e-06262224984162
Pubmed

Innate immunity of surfactant protein A in experimental otitis media.

SFTPA2 SFTPA1

3.13e-06262231378117
Pubmed

Surfactant Protein A, a Novel Regulator for Smooth Muscle Phenotypic Modulation and Vascular Remodeling-Brief Report.

SFTPA2 SFTPA1

3.13e-06262233267655
Pubmed

Effect of cysteine 85 on biochemical properties and biological function of human surfactant protein A variants.

SFTPA2 SFTPA1

3.13e-06262217580966
Pubmed

Isolation and characterization of cDNA clones for the 35-kDa pulmonary surfactant-associated protein.

SFTPA2 SFTPA1

3.13e-0626223755136
Pubmed

Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection.

SFTPA2 SFTPA1

3.13e-06262211237812
Pubmed

Human SP-A protein variants derived from one or both genes stimulate TNF-alpha production in the THP-1 cell line.

SFTPA2 SFTPA1

3.13e-06262210781424
Pubmed

SP-A is necessary for increased clearance of alveolar DPPC with hyperventilation or secretagogues.

SFTPA2 SFTPA1

3.13e-06262212676766
Pubmed

Differential effects of innate immune variants of surfactant protein-A1 (SFTPA1) and SP-A2 (SFTPA2) in airway function after Klebsiella pneumoniae infection and sex differences.

SFTPA2 SFTPA1

3.13e-06262229394894
Pubmed

Surfactant protein-A suppresses eosinophil-mediated killing of Mycoplasma pneumoniae in allergic lungs.

SFTPA2 SFTPA1

3.13e-06262222384248
Pubmed

Surfactant protein A enhances production of secretory leukoprotease inhibitor and protects it from cleavage by matrix metalloproteinases.

SFTPA2 SFTPA1

3.13e-06262219155504
Pubmed

Surfactant Protein A can Affect the Surface Tension of the Eustachian Tube and Macrophage Migration.

SFTPA2 SFTPA1

3.13e-06262236102297
Pubmed

Surfactant protein A deficiency exacerbates renal interstitial fibrosis following obstructive injury in mice.

SFTPA2 SFTPA1

3.13e-06262227916681
Pubmed

Surfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway.

SFTPA2 SFTPA1

3.13e-06262212959932
Pubmed

Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition.

SFTPA2 SFTPA1

3.13e-06262215044702
Pubmed

Structural comparison of recombinant pulmonary surfactant protein SP-A derived from two human coding sequences: implications for the chain composition of natural human SP-A.

SFTPA2 SFTPA1

3.13e-0626221986781
Pubmed

Role of surfactant protein-A (SP-A) in lung injury in response to acute ozone exposure of SP-A deficient mice.

SFTPA2 SFTPA1

3.13e-06262217307210
Pubmed

Surfactant protein A is a required mediator of keratinocyte growth factor after experimental marrow transplantation.

SFTPA2 SFTPA1

3.13e-06262212740217
Pubmed

Surfactant protein-A plays an important role in lung surfactant clearance: evidence using the surfactant protein-A gene-targeted mouse.

SFTPA2 SFTPA1

3.13e-06262218083768
Pubmed

Structural characterisation of human proteinosis surfactant protein A.

SFTPA2 SFTPA1

3.13e-06262211087951
Pubmed

Surfactant protein A modulates induction of regulatory T cells via TGF-β.

SFTPA2 SFTPA1

3.13e-06262222474025
Pubmed

The collagen-like region of surfactant protein A (SP-A) is required for correction of surfactant structural and functional defects in the SP-A null mouse.

SFTPA2 SFTPA1

3.13e-06262211504713
Pubmed

Surfactant protein A promotes western diet-induced hepatic steatosis and fibrosis in mice.

SFTPA2 SFTPA1

3.13e-06262238553537
Pubmed

Surfactant protein-A inhibits Aspergillus fumigatus-induced allergic T-cell responses.

SFTPA2 SFTPA1

3.13e-06262216120217
Pubmed

SP-A2 contributes to miRNA-mediated sex differences in response to oxidative stress: pro-inflammatory, anti-apoptotic, and anti-oxidant pathways are involved.

SFTPA2 SFTPA1

3.13e-06262229202868
Pubmed

The alveolar macrophage toponome of female SP-A knockout mice differs from that of males before and after SP-A1 rescue.

SFTPA2 SFTPA1

3.13e-06262235322074
Pubmed

Surfactant protein A regulates surfactant phospholipid clearance after LPS-induced injury in vivo.

SFTPA2 SFTPA1

3.13e-06262212060563
Pubmed

Surfactant protein A reduces TLR4 and inflammatory cytokine mRNA levels in neonatal mouse ileum.

SFTPA2 SFTPA1

3.13e-06262233510368
Pubmed

Surfactant Protein-A Protects against IL-13-Induced Inflammation in Asthma.

SFTPA2 SFTPA1

3.13e-06262232245819
Pubmed

Characteristics of surfactant from SP-A-deficient mice.

SFTPA2 SFTPA1

3.13e-0626229700084
Pubmed

Genetic complexity of the human innate host defense molecules, surfactant protein A1 (SP-A1) and SP-A2--impact on function.

SFTPA2 SFTPA1

3.13e-06262219392648
Pubmed

Polymorphisms in the surfactant protein a gene are associated with the susceptibility to recurrent urinary tract infection in chinese women.

SFTPA2 SFTPA1

3.13e-06262220448439
Pubmed

Humanized SFTPA1 and SFTPA2 transgenic mice reveal functional divergence of SP-A1 and SP-A2: formation of tubular myelin in vivo requires both gene products.

SFTPA2 SFTPA1

3.13e-06262220048345
Pubmed

Novel role for surfactant protein A in gastrointestinal graft-versus-host disease.

SFTPA2 SFTPA1

3.13e-06262222508928
Pubmed

Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer.

SFTPA2 SFTPA1

3.13e-06262232855221
Pubmed

Surfactant protein A suppresses lipopolysaccharide-induced IL-10 production by murine macrophages.

SFTPA2 SFTPA1

3.13e-06262211342662
Pubmed

Surfactant protein A-deficient mice are susceptible to group B streptococcal infection.

SFTPA2 SFTPA1

3.13e-0626229126996
Pubmed

Relationship between surfactant protein A polymorphisms and allergic rhinitis in a Chinese Han population.

SFTPA2 SFTPA1

3.13e-06262220963503
Pubmed

Human SP-A1 (SFTPA1) variant-specific 3' UTRs and poly(A) tail differentially affect the in vitro translation of a reporter gene.

SFTPA2 SFTPA1

3.13e-06262220693318
Pubmed

Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection.

SFTPA2 SFTPA1

3.13e-06262211839553
Pubmed

Type IV pilus glycosylation mediates resistance of Pseudomonas aeruginosa to opsonic activities of the pulmonary surfactant protein A.

SFTPA2 SFTPA1

3.13e-06262225605768
Pubmed

Surfactant protein A decreases lung injury and mortality after murine marrow transplantation.

SFTPA2 SFTPA1

3.13e-06262212204891
Pubmed

Type IV pilus of Pseudomonas aeruginosa confers resistance to antimicrobial activities of the pulmonary surfactant protein-A.

SFTPA2 SFTPA1

3.13e-06262224080545
Pubmed

Lung development in the mouse embryo.

SFTPA2 SFTPA1

3.13e-0626222050021
Pubmed

Role of surfactant protein-A in nitric oxide production and mycoplasma killing in congenic C57BL/6 mice.

SFTPA2 SFTPA1

3.13e-06262212959946
Pubmed

Murine pulmonary surfactant SP-A gene: cloning, sequence, and transcriptional activity.

SFTPA2 SFTPA1

3.13e-0626221443158
Pubmed

Surfactant Protein A and B Gene Polymorphisms and Risk of Respiratory Distress Syndrome in Late-Preterm Neonates.

SFTPA2 SFTPA1

3.13e-06262227835691
Pubmed

Surfactant protein-A enhances ureaplasmacidal activity in vitro.

SFTPA2 SFTPA1

3.13e-06262220197455
Pubmed

The role of pulmonary collectin N-terminal domains in surfactant structure, function, and homeostasis in vivo.

SFTPA2 SFTPA1

9.37e-06362212015304
Pubmed

Surfactant protein-A modulates LPS-induced TLR4 localization and signaling via β-arrestin 2.

SFTPA2 SFTPA1

9.37e-06362223536892
Pubmed

Inhibitory effects of surfactant protein A on surfactant phospholipid hydrolysis by secreted phospholipases A2.

SFTPA2 SFTPA1

9.37e-06362212847272
Pubmed

Surfactant proteins SP-A and SP-D: structure, function and receptors.

SFTPA2 SFTPA1

9.37e-06362216213021
Pubmed

Negligible role for pneumococcal surface protein A (PspA) and pneumococcal surface protein C (PspC) in the nasopharyngeal colonization of mice with a serotype 6B pneumococcal strain.

SFTPA2 SFTPA1

9.37e-06362237839762
Pubmed

Surfactant protein A modulates cell surface expression of CR3 on alveolar macrophages and enhances CR3-mediated phagocytosis.

SFTPA2 SFTPA1

9.37e-06362219155216
Pubmed

Interaction of surfactant protein A with peroxiredoxin 6 regulates phospholipase A2 activity.

SFTPA2 SFTPA1

9.37e-06362216330552
Pubmed

Surfactant protein A inhibits lipopolysaccharide-induced in vivo production of interleukin-10 by mononuclear phagocytes during lung inflammation.

SFTPA2 SFTPA1

9.37e-06362212594061
Pubmed

Macrophage-independent fungicidal action of the pulmonary collectins.

SFTPA2 SFTPA1

9.37e-06362212857753
Pubmed

Lung surfactant proteins involved in innate immunity.

SFTPA2 SFTPA1

9.37e-06362210047533
Pubmed

Surfactant protein-A inhibits mycoplasma-induced dendritic cell maturation through regulation of HMGB-1 cytokine activity.

SFTPA2 SFTPA1

9.37e-06362220810986
Pubmed

Altered surfactant function and structure in SP-A gene targeted mice.

SFTPA2 SFTPA1

9.37e-0636228790375
Pubmed

Role of surfactant proteins A and D in sepsis-induced acute kidney injury.

SFTPA2 SFTPA1

9.37e-06362225255378
Pubmed

Pulmonary collectins modulate strain-specific influenza a virus infection and host responses.

SFTPA2 SFTPA1

9.37e-06362215280465
Pubmed

Foetal lung maturation in 11beta-hydroxysteroid dehydrogenase type 1 knockout mice.

SFTPA2 SFTPA1

9.37e-06362212439781
Pubmed

Disruption of the SP-A/SP-R210L (MYO18Aα) pathway prolongs gestation and reduces fetal survival during lipopolysaccharide-induced parturition in late gestation.

SFTPA2 SFTPA1

9.37e-06362238349123
Cytoband12q21.31

LRRIQ1 METTL25

2.71e-041862212q21.31
CytobandEnsembl 112 genes in cytogenetic band chr15q24

NEO1 PEAK1 ARIH1

6.18e-04122623chr15q24
Cytoband10q22.3

SFTPA2 SFTPA1

1.56e-034362210q22.3
GeneFamilyCollectins

SFTPA2 SFTPA1

2.81e-0410462491
GeneFamilyLaminin subunits

LAMB4 LAMA2

4.11e-0412462626
CoexpressionAtlasratio_StemCell_vs_induced-Ectoderm_top-relative-expression-ranked_1000_k-means-cluster#2

NPR1 UNC45B IL20RA NEB ATP10A ABTB2

3.04e-06140616ratio_SC_vs_ECTO_1000_K2
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP126 LRRIQ1 SFTPA2 HYDIN ALOX15B MAP3K19

2.90e-07193626bdb7401dd9059032f930f2b575f2ef8e504b6594
ToppCell368C-Epithelial_cells-Epithelial-A_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells)

CFAP126 SFTPA2 IL20RA SFTPA1 ALOX15B

3.31e-0616462585f53d184fa70e3eb1af655807f32b17ddbfb304
ToppCell368C-Epithelial_cells-Epithelial-A_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells)

CFAP126 SFTPA2 IL20RA SFTPA1 ALOX15B

3.31e-06164625144ba070a1ede71684224cc6d4ead3b7e6a7b4c6
ToppCellfacs-Lung-EPCAM-3m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRRIQ1 RAB11FIP4 NEB ATP10A HYDIN

3.95e-0617062582ccba6ec53f6ca0d19949a1277434c565af2983
ToppCellfacs-Lung-EPCAM-3m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRRIQ1 RAB11FIP4 NEB ATP10A HYDIN

3.95e-06170625ab19ea729ed8c8361c870e79893d1a95a1e487fa
ToppCellCOPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class

DPYD SFTPA2 AFF3 SFTPA1 ALOX15B

6.28e-06187625030af361f8bdcd0aff4ec1922702833325cf74d8
ToppCellIPF-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class

NPR1 SFTPA2 AFF3 SFTPA1 ALOX15B

6.44e-061886255f5fad2773e421760e67dbace23fd1f847a2e1e0
ToppCellCOPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class

SFTPA2 AFF3 IL20RA SFTPA1 MYO1B

6.44e-06188625eb6d79d733b53f64ca615bb777c64ed456866549
ToppCell3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP126 LRRIQ1 FANCI MAP3K19 SHISA8

6.78e-061906250adb24dafa077156bbc73a8d8cbf3d9eeb6e08df
ToppCell3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP126 LRRIQ1 FANCI MAP3K19 SHISA8

6.78e-0619062505455775845f4ded5c27e7b83242078d23162aaf
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP126 LRRIQ1 HYDIN MAP3K19 SHISA8

6.96e-06191625683e5c7e6173644f01e67c98ab7b75d7cb9cce99
ToppCell367C-Epithelial_cells|367C / Donor, Lineage, Cell class and subclass (all cells)

CFAP126 LRRIQ1 SFTPA2 SFTPA1 ALOX15B

6.96e-06191625d31975fc33779b0b3ff1a50d7c64fec8d08be4d4
ToppCellControl-Multiplet-Multiplet|World / Disease state, Lineage and Cell class

SFTPA2 SYNE2 AFF3 SFTPA1 MYO1B

7.14e-061926251bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCellControl-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class

DPYD SFTPA2 AFF3 SFTPA1 ALOX15B

7.50e-06194625a01de094f7bfd099bcbb2f94224690a2efb887b4
ToppCellControl-Multiplet|Control / Disease state, Lineage and Cell class

SFTPA2 SYNE2 AFF3 SFTPA1 MYO1B

7.69e-06195625618900c80bea09d46dad3f741bd1bff8bf0a64ee
ToppCellControl-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class

SFTPA2 SYNE2 AFF3 SFTPA1 MYO1B

7.69e-0619562506ac685855e14e4dd2cbe6d0e73f894f2eeff91f
ToppCellBronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations

DPYD ARID1B SFTPA2 AFF3 SFTPA1

7.89e-06196625ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCellASK440-Epithelial-Type_2|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq

SFTPA2 AFF3 SFTPA1 MYO1B ALOX15B

7.89e-06196625754b4202b617165c6994a0b5a9b1e486dccdd44d
ToppCelldistal-Epithelial-Alveolar_Epithelial_Type_2-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

SFTPA2 IL20RA SFTPA1 MYO1B ALOX15B

8.28e-0619862519eefd05573fbaed654af52bf0f8a26092b8b229
ToppCellmedial-2-Epithelial-Alveolar_Epithelial_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

SFTPA2 IL20RA SFTPA1 MYO1B ALOX15B

8.28e-06198625102a4cbb138adbfba11ed955420095daa098532f
ToppCellControl_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type

CFAP126 LRRIQ1 SFTPA2 HYDIN MAP3K19

8.28e-06198625e6863238e022ecfb6a8e3f4b7661b376e92c5d8f
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CFAP126 ATP5PO LRRIQ1 HYDIN MAP3K19

8.28e-061986251847ce8c344c8a3e50f3cbbf758a38aba69f85b0
ToppCellmedial-Epithelial-Alveolar_Epithelial_Type_2-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

SFTPA2 IL20RA SFTPA1 MYO1B ALOX15B

8.28e-061986257caeed2d5dc78866023c8f38edcec9886baa9f2c
ToppCelldistal-1-Epithelial-Alveolar_Epithelial_Type_2|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

SFTPA2 IL20RA SFTPA1 MYO1B ALOX15B

8.28e-06198625ce9d6b2a93c7b304414ce1b8b1a09562cf581278
ToppCelldistal-Epithelial-Alveolar_Epithelial_Type_2-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

SFTPA2 IL20RA SFTPA1 MYO1B ALOX15B

8.28e-06198625de5748c2b66ecc432974cf095ecd241369579f7c
ToppCellControl_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type

CFAP126 LRRIQ1 SFTPA2 HYDIN MAP3K19

8.28e-06198625e7aa42e5fbd42c68f50cda4a8f3aa464c862c007
ToppCellmedial-Epithelial-Alveolar_Epithelial_Type_2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

SFTPA2 IL20RA SFTPA1 MYO1B ALOX15B

8.28e-0619862553e5d76831d70b9a476f3ef3a81e13eda974d543
ToppCellMild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass

CFAP126 LRRIQ1 IL20RA HYDIN MAP3K19

8.49e-0619962581115bbd2c10bfdd38376d2075f03a59c31870d2
ToppCelldistal-1-Epithelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

SFTPA2 IL20RA SFTPA1 MYO1B ALOX15B

8.49e-061996259086dbb60863c3da2cc5d0a310f28596a01c52ca
ToppCellLPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CFAP126 LRRIQ1 SFTPA2 HYDIN MAP3K19

8.49e-0619962560919c2af31d39a2d36d7bc432e43dab2a4e05fb
ToppCellMild-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass

CFAP126 LRRIQ1 IL20RA HYDIN MAP3K19

8.49e-06199625ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18
ToppCellCOVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type

DPYD SFTPA2 BAZ1A SFTPA1 ATP10A

8.49e-06199625155b03b859157013e9142e9248551369127d9204
ToppCellMild-Epithelial-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass

CFAP126 LRRIQ1 IL20RA HYDIN MAP3K19

8.49e-0619962591308b255783ad4029e5575028c18d7550832c51
ToppCellLPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CFAP126 LRRIQ1 SFTPA2 HYDIN MAP3K19

8.49e-061996256aca164bbbb961f34b1e6f1857f91ade5c059405
ToppCelldistal-2-Epithelial-Alveolar_Epithelial_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

SFTPA2 IL20RA SFTPA1 MYO1B ALOX15B

8.49e-0619962521b44031bc5182ee23ba5e206042b2e5e4ee0c3c
ToppCellBiopsy_Control_(H.)-Epithelial-Differentiating_Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

CFAP126 LRRIQ1 HYDIN MAP3K19 SHISA8

8.70e-06200625a552a99f5e4fa00dfb7775e5a3e1f62f1530d104
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ARID1B SYNE2 ITSN2 JMJD1C HERC5

8.70e-0620062512f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellBrain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm|3m / Sample Type, Dataset, Time_group, and Cell type.

MYH2 HOXD8 UNC45B IL20RA NEB

8.70e-06200625538ae964db58c4acafe93f735b3e03fc08fdaac6
ToppCellGlobus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Pdyn_(Striatum,_patch_dSPNs)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

TMC1 HOXD8 SLC26A5

6.21e-05556236575ee5274f1044e17f4a5204375acc82ef16182
ToppCellGlobus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Pdyn_(Striatum,_patch_dSPNs)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

TMC1 HOXD8 SLC26A5

6.21e-055562321a72cc6f12889509dbfaa9929be48d00f5f6345
ToppCellControl-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CFAP126 LRRIQ1 HYDIN MAP3K19

6.31e-051546244e3bc24043144143842627cacf6f90dda2228910
ToppCellControl-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CFAP126 LRRIQ1 HYDIN MAP3K19

6.31e-051546247556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CFAP126 LRRIQ1 HYDIN MAP3K19

6.47e-051556245f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK5 TMC1 TEX11 ATP10A

6.47e-05155624e7f49e2fdaf184fa6b4e685518004e7deff1316d
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CFAP126 LRRIQ1 HYDIN MAP3K19

6.47e-051556240944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCellfacs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STAB2 IL20RA TERB2 HYDIN

6.47e-051556248fdda4e3657ac56188ae88ed3caf145f4d9d1567
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK5 TMC1 TEX11 ATP10A

6.47e-051556245a872ca70ae8c30b57f45a6772d7bf565e0c2663
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYH2 AFF3 NEB SHISA8

6.63e-05156624d81e78bec5c8a3f3ec9e1447ebab2c5805b815eb
ToppCellNS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

NAALAD2 LRRIQ1 FANCI HYDIN

6.80e-05157624410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell367C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

SFTPA2 AFF3 SFTPA1 ALOX15B

8.05e-05164624b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2
ToppCellCiliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id

CFAP126 LRRIQ1 HYDIN MAP3K19

8.05e-05164624fd30c55d0d75ef8b9396435d836187168095152b
ToppCell367C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

SFTPA2 AFF3 SFTPA1 ALOX15B

8.05e-051646243aea6207a011ad55a1aeb2ed9fb54d31b23694b5
ToppCellCiliated_cells-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id

CFAP126 LRRIQ1 HYDIN MAP3K19

9.25e-051706248b7ef1464ea589886b575ebad5447b085cbdcdba
ToppCellCiliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id

CFAP126 LRRIQ1 HYDIN MAP3K19

9.68e-05172624187ae91148d293537afc77e10da2b64302322224
ToppCellfacs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CFAP126 LRRIQ1 HTR5A MAP3K19

1.01e-04174624f1510b0f7771936adf29ae3572feab55db31832b
ToppCellfacs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CFAP126 LRRIQ1 HTR5A MAP3K19

1.01e-041746245d5d2fc60afff47f997751e8e9ca1367a22d19ec
ToppCellfacs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DPYD LAMA2 IGLL1 HYDIN

1.03e-04175624887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCellCiliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

CFAP126 LRRIQ1 HYDIN MAP3K19

1.06e-041766241c364155f46b9a7c995bdc2cc2333c437cd90f5b
ToppCellfacs-Aorta|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NPR1 HOXD8 UNC45B HYDIN

1.06e-041766240b3491451be02c18a16cdb875645be47eb867a7f
ToppCellCiliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

CFAP126 LRRIQ1 HYDIN MAP3K19

1.08e-04177624c38138fb5ad9766c2d240811210c854338cd612e
ToppCellCiliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id

CFAP126 LRRIQ1 HYDIN MAP3K19

1.10e-04178624255473ee6df8a13079fb3bb61038162a40cb4c2c
ToppCellwk_08-11-Epithelial-PNS-Late_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

CHL1 DOCK5 HOXD8 CPO

1.10e-04178624a7301c0bba03d10feacc02e3f929d9a9235fd25b
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP126 LRRIQ1 MAP3K19 SHISA8

1.13e-04179624d15182c668d7c37be8214cad9f1fe35d1409c9a1
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP126 LRRIQ1 MAP3K19 SHISA8

1.13e-04179624e22a275a7c0ed19113c833a75d6c49fcc19aa13a
ToppCellP28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

CHL1 DOCK5 DPYD SLC29A2

1.15e-041806241e819c5c87704ec6535dfeaae56561895e239d07
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP126 LRRIQ1 HYDIN MAP3K19

1.15e-04180624adf5db5bfa9a38b1227ab0beccd8d6f3eea67ac0
ToppCellfacs-Trachea-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFAP126 LRRIQ1 IGLL1 HYDIN

1.15e-04180624cf6e9f757afeb342c5023f6e6152a1b4d0d164b4
ToppCellCiliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id

CFAP126 LRRIQ1 TERB2 HYDIN

1.15e-04180624bdea5ec6b60fc8c7cce4d71db5da74ac8675e211
ToppCellControl-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations)

SFTPA2 AFF3 SFTPA1 ALOX15B

1.15e-04180624198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCelldroplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UNC45B SYNE2 MYO1B PEAK1

1.18e-0418162492d44892bb15771f0ab5fe61879b204b0acbd9b3
ToppCell3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DOCK5 STAB2 HOXD8 PEAK1

1.18e-04181624e898ecb8d8f2eb2204225b7b0d665cadcd241139
ToppCellAT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

SFTPA2 SFTPA1 MYO1B ALOX15B

1.18e-04181624ed0ea67f0607073aedf153f8d1073b35e46127c3
ToppCell10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue

ARID1B MAN2A1 SYNE2 JMJD1C

1.18e-04181624f2315414e714ac86211546a935660c4be6e85f1b
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFAP126 LRRIQ1 IGLL1 HYDIN

1.20e-04182624587636c0f127231de21acd8aa632b74ff22ca8c2
ToppCellwk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

CFAP126 LRRIQ1 HYDIN MAP3K19

1.20e-04182624000eca5baa6eb2335a1e6d76a13fff5382b0e150
ToppCellCiliated_cells-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id

CFAP126 LRRIQ1 HYDIN MAP3K19

1.20e-04182624e44c4810dc7d51a76b86d7623f8e4c4d8b4bf2fc
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFAP126 LRRIQ1 IGLL1 HYDIN

1.20e-04182624adfadd7893e74b3002f13f00875e3667d3493e0c
ToppCell5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DOCK5 STAB2 HOXD8 SLC26A5

1.20e-0418262453c267ee327e116dbd89d5927ed3bdf78d25ee62
ToppCellCiliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id

CFAP126 LRRIQ1 HYDIN MAP3K19

1.20e-04182624e93968f800bfeb258e4e834fc8bf92d1cb72cd73
ToppCell367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells)

CFAP126 LRRIQ1 HYDIN MAP3K19

1.23e-04183624b1336eac5adbffade4cef3e0ce3de75a781ae365
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

SFTPA2 AFF3 SFTPA1 ALOX15B

1.23e-041836246847c1252d6bb105524f812658112517fd351eab
ToppCellCalu_3-infected|Calu_3 / Cell line, Condition and Strain

BAZ1A SYNE2 JMJD1C HERC5

1.23e-041836248f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCellCOPD-Epithelial-ATII|World / Disease state, Lineage and Cell class

SFTPA2 AFF3 SFTPA1 MYO1B

1.23e-041836248e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells)

CFAP126 LRRIQ1 HYDIN MAP3K19

1.23e-04183624cc57dcb59c68d68a546dc108dd9e009b2aab8da5
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CHL1 AFF3 NEB SHISA8

1.23e-0418362401664fce6b70a02c9d39d747b6a6aabc86d57bc2
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STAB2 TEX11 NEB HYDIN

1.25e-041846242cbed6462fea2622871bb7e49b0df3d984239281
ToppCell367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells)

SFTPA2 SFTPA1 MYO1B ALOX15B

1.25e-041846240ba243cbf69b4fe6ae100a7f0314317bec38026c
ToppCellCOVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations)

SFTPA2 AFF3 SFTPA1 ALOX15B

1.25e-04184624369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STAB2 TEX11 NEB HYDIN

1.25e-04184624ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STAB2 TEX11 NEB HYDIN

1.25e-041846242b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellCiliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

CFAP126 LRRIQ1 HYDIN MAP3K19

1.25e-0418462407c5a9633ccdcd18771e3230d6198a55c400afa6
ToppCell367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells)

SFTPA2 SFTPA1 MYO1B ALOX15B

1.25e-041846242a8338e94937686a148b5433515700ca0f674058
ToppCellCiliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id

CFAP126 LRRIQ1 HYDIN MAP3K19

1.28e-041856244fc7113d3dadc716ec5a8e62b58543cc00ce5b16
ToppCellIPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class

SFTPA2 SFTPA1 MYO1B ALOX15B

1.28e-04185624563b4e6d92bb5d77a3829556116a8e99aebac615
ToppCellAT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id

SFTPA2 SFTPA1 MYO1B ALOX15B

1.28e-041856243b3268e3f99121124e33086cac88479808d31630
ToppCellCiliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

CFAP126 LRRIQ1 HYDIN MAP3K19

1.28e-04185624f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCellCiliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id

CFAP126 LRRIQ1 HYDIN MAP3K19

1.28e-04185624d77ca57b02125a3a57a37f4aed20c89803b7d551
ToppCellIPF-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class

CHL1 DOCK5 TCTN3 AFF3

1.28e-04185624ced17f69486591c3cbbdc852a3e82c3f3a4a30d7
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK5 NPR1 MYO1B ATP10A

1.28e-04185624b848b63aff4d9dbb9e66a85876d4c7c6dacd0579
ToppCellIPF-Epithelial-ATII|World / Disease state, Lineage and Cell class

SFTPA2 SFTPA1 MYO1B ALOX15B

1.31e-041866246a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947
Diseasejuvenile idiopathic arthritis

LAMB4 AFF3 LAMA2 JMJD1C

1.60e-0574604EFO_0002609
Diseaselevel of leukocyte immunoglobulin-like receptor subfamily B member 4 in blood serum

SFTPA2 SFTPA1

4.05e-055602OBA_2042200
Diseaselevel of prosaposin in blood serum

SFTPA2 SFTPA1

4.05e-055602OBA_2044552
Diseasenewborn respiratory distress syndrome (biomarker_via_orthology)

SFTPA2 SFTPA1

6.07e-056602DOID:12716 (biomarker_via_orthology)
DiseaseCongenital muscular dystrophy (disorder)

SYNE2 LAMA2

6.07e-056602C0699743
Diseasebeta-citrylglutamate measurement

NAALAD2 JMJD1C

8.48e-057602EFO_0800060
Diseasenewborn respiratory distress syndrome (is_implicated_in)

SFTPA2 SFTPA1

8.48e-057602DOID:12716 (is_implicated_in)
Diseaseleukocyte immunoglobulin-like receptor subfamily B member 4 measurement

SFTPA2 SFTPA1

1.13e-048602EFO_0801768
Diseasefetuin-B measurement

JMJD1C FETUB

1.81e-0410602EFO_0008128
Diseasememory performance

PDS5B DPYD NEO1 TMC1 SYNE2 NEB

1.82e-04409606EFO_0004874
Diseasecomplement C1q tumor necrosis factor-related protein 1 measurement

SFTPA2 SFTPA1

2.65e-0412602EFO_0801493
DiseaseLeigh disease (implicated_via_orthology)

ATP5PO NDUFA10

2.65e-0412602DOID:3652 (implicated_via_orthology)
Diseasegranulins measurement

SFTPA2 SFTPA1

2.65e-0412602EFO_0008141
DiseaseHamman-Rich syndrome

SFTPA2 SFTPA1

3.64e-0414602C0085786
Diseasebacterial pneumonia (biomarker_via_orthology)

SFTPA2 SFTPA1

3.64e-0414602DOID:874 (biomarker_via_orthology)
Diseasecortical thickness

PDS5B SEPSECS ARID1B NEO1 LRRIQ1 BAZ1A LAMA2 RAB11FIP4 JMJD1C

3.92e-041113609EFO_0004840
DiseaseFamilial Idiopathic Pulmonary Fibrosis

SFTPA2 SFTPA1

7.55e-0420602C4721952
DiseaseIdiopathic Pulmonary Fibrosis

SFTPA2 SFTPA1

8.33e-0421602C1800706
Diseasebrain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement

ATP10A ABTB2

9.15e-0422602EFO_0004277, EFO_0006790, EFO_0006792, EFO_0006797, EFO_0006798
Diseasecongenital diaphragmatic hernia (biomarker_via_orthology)

SFTPA2 SFTPA1

1.09e-0324602DOID:3827 (biomarker_via_orthology)
Diseasefactor VIII measurement, von Willebrand factor measurement

STAB2 DDX31

1.38e-0327602EFO_0004629, EFO_0004630
Diseasesensory perception of smell

STAB2 NDUFA10

1.59e-0329602GO_0007608
DiseaseIschemic stroke, von Willebrand factor measurement

STAB2 DDX31

1.71e-0330602EFO_0004629, HP_0002140
Diseaseunipolar depression, bipolar disorder, seasonality measurement

SFTPA2 SFTPA1

1.71e-0330602EFO_0003761, EFO_0006876, MONDO_0004985
DiseaseAutistic Disorder

DPYD HTR5A ATP10A JMJD1C

1.98e-03261604C0004352

Protein segments in the cluster

PeptideGeneStartEntry
YSKALIDYFKNSSKA

AFF3

1086

P51826
YKDVRQIFNNSKAYT

BRWD3

1391

Q6RI45
DIKSFITSIANKNYY

DPYD

96

Q12882
SAASSLKKQYIQYLF

ARID1B

1206

Q8NFD5
QVFAKTAYYKGNLVA

NPR1

551

P16066
AANALKAKYGTNYRV

CPO

266

Q8IVL8
KIRSKTQNYLNVYAA

ATP10A

791

O60312
YATALYSAASKQNKL

ATP5PO

41

P48047
GADVTSANAKYRYQK

BAZ1A

561

Q9NRL2
GLAQIYKKYALQSAA

PDS5B

411

Q9NTI5
SLYEAKNLFAAQTKA

RAB11FIP4

571

Q86YS3
ALYAAVNKKPTSAAY

ITSN2

966

Q9NZM3
YVFAFYLKKNNQSII

ARIH1

476

Q9Y4X5
SFISYVQNKSKSLNY

FANCI

1211

Q9NVI1
QLKKSYSLDYDQALA

OR6N1

261

Q8NGY5
SNSHLADYVLYKNKV

MAN2A1

726

Q16706
SNLNATTKYKFYLRA

CHL1

981

O00533
VNPLYSKYKAAAAAA

HOXD8

6

P13378
EAFALAAKYYSVQNL

METTL25

106

Q8N6Q8
KAALAAAQYKSSNAS

JMJD1C

1486

Q15652
AKYNNENTSKQYSLF

FETUB

176

Q9UGM5
AKNALESYTYNIKQT

HSPA2

541

P54652
NLKNISELFYYAQKA

RHOT1

151

Q8IXI2
YADFKQRYKVLNASA

MYH2

721

Q9UKX2
ASYAKDPLNNYAVKI

PEAK1

1346

Q9H792
ATAAFKAYSNIKDYI

LAMA2

1921

P24043
AKKALQSFIQAYATY

DDX31

711

Q9H8H2
YSNLKYNVSVLNTKS

IL20RA

176

Q9UHF4
AAVKIQAKYKAFVAY

LRRIQ1

286

Q96JM4
SAYLQDIENAYKKTF

NDUFA10

231

O95299
SKYINYIFNDSVKAV

HERC5

866

Q9UII4
SKQSNNKYAASSYLS

IGLL1

166

P15814
LSGKSANAVSVAKYY

HYDIN

2046

Q4G0P3
ATLAYVKLSKVLNFY

DOCK5

726

Q9H7D0
LIYTAFNKNYNSAFK

HTR5A

336

P47898
SANQYEKAFSSKYLQ

CFAP126

6

Q5VTH2
NASIADSSENIKKYY

LAMB4

1301

A4D0S4
KDKLYRSASQALQAY

LAS2

41

Q8IYD9
QAIHKYNAYRKAASV

POLB

31

P06746
YLSSRKNESSVAKNY

MAP3K19

366

Q56UN5
ASAASALKDVSYKIY

NXF2

171

Q9GZY0
ELNIKYSTAKNANFY

ALOX15B

171

O15296
LKFARYYLANKSSQA

SLC29A2

216

Q14542
KSLKAGLDYNRSYQN

SYNE2

4626

Q8WXH0
YANSDLYSNALKRKT

SLC26A5

546

P58743
ANTKYKNANATTLSY

NEO1

901

Q92859
YAKYATFKAAALKAA

SHISA8

256

B8ZZ34
NEAIASFVKKYNTYA

SFTPA2

171

Q8IWL1
NEAIASFVKKYNTYA

SFTPA1

171

Q8IWL2
LAIYYLNATAKGQKA

TMC1

711

Q8TDI8
SAVNTYKYAKIHNAP

ABTB2

951

Q8N961
DYKAATNSYSQALKL

UNC45B

21

Q8IWX7
SYNKYDKDLSQSSNL

ZNF267

296

Q14586
AYYLSAVANAKIKNS

TERB2

66

Q8NHR7
KAYDYLVQNTSFANK

TPP2

506

P29144
TKYYDKALNAVNLAN

TEX11

281

Q8IYF3
TMATYNQLSYAQKAK

STAB2

2226

Q8WWQ8
SYLSNQIKKLSEAYN

SEPSECS

346

Q9HD40
ALNAASYYNFTVLKV

TCTN3

271

Q6NUS6
YASNKASKAASVLLY

PKP2

831

Q99959
YAQQKRYQQTKSSAL

MYO1B

741

O43795
AEALKNYAASIYNLS

NAALAD2

591

Q9Y3Q0
NYAASIYNLSKKHDQ

NAALAD2

596

Q9Y3Q0
IQAKKAYDLQSDALY

NEB

3856

P20929